Since 2011, Credo Diagnostics Biomedical has developed, manufactured, and commercialized innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health.

• The standalone platform integrates a full workflow of nucleic acid extraction and real-time Polymerase Chain Reaction (real-time PCR) testing in a cartridge-based design. The instrument has expanded multiplex capacity can detect up to 6 targets with a wide range of sample types.
• An innovative rapid molecular diagnostic instrument based on Polymerase Chain Reaction (PCR) technology, VitaPCR™ allows significantly faster testing than any other laboratory molecular diagnostic method with higher accuracy than conventional rapid testing, in just 20 minutes from sample to results, at the Point-of-Care testing.